Literature DB >> 3758144

Potential pulmonary uptake and clearance of morphine in postoperative patients.

M P Persson, L Wiklund, P Hartvig, L Paalzow.   

Abstract

The influence of lung uptake and lung clearance on the disposition of morphine was studied in surgical patients. In the postoperative period morphine was given intravenously by a two-rate infusion regimen. Under steady-state conditions samples of mixed central venous blood (pulmonary artery) and peripheral arterial blood (radial artery) were taken simultaneously and at the same time cardiac output was measured. The concentration differences between venous and arterial blood were used to calculate the extraction ratio of morphine across the lung. In all patients there was marked pulmonary uptake, but the concentration differences in most of them were small under steady-state conditions. The extraction ratio (mean +/- SD) across the lung was 0.06 +/- 0.10, implying insignificant lung clearance. However, in two patients, both with diabetes mellitus, there was a significant concentration gradient, indicating that the lung could contribute to the total body elimination of morphine. On the other hand, the total clearance was similar in diabetic and nondiabetic patients (1190 and 1150 ml/min, respectively), implying that pulmonary clearance would have no significant influence on the kinetics of morphine. A physiologically based pharmacokinetic model was used to describe the disposition of morphine in post-operative patients. The model allowed simulation of pulmonary diffusion, uptake and elimination and supported conclusions based on model-independent experimental data.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3758144     DOI: 10.1007/bf00542416

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  21 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  The diposi tion of morphine in surgical patients.

Authors:  B A Berkowitz; S H Ngai; J C Yang; J Hempstead; S Spector
Journal:  Clin Pharmacol Ther       Date:  1975-06       Impact factor: 6.875

3.  Prediction of blood volume in normal human adults.

Authors:  Samuel B Nadler; John H Hidalgo; Ted Bloch
Journal:  Surgery       Date:  1962-02       Impact factor: 3.982

4.  Pharmacokinetic aspects of intravenous regional anesthesia.

Authors:  G T Tucker; R A Boas
Journal:  Anesthesiology       Date:  1971-06       Impact factor: 7.892

5.  Pharmacokinetic aspects of optimal pain treatment.

Authors:  L K Paalzow
Journal:  Acta Anaesthesiol Scand Suppl       Date:  1982

6.  Absence of metabolism of morphine during accumulation by isolated perfused rabbit lung.

Authors:  M E Davis; H M Mehendale
Journal:  Drug Metab Dispos       Date:  1979 Nov-Dec       Impact factor: 3.922

7.  Age-related morphine kinetics.

Authors:  J A Owen; D S Sitar; L Berger; L Brownell; P C Duke; P A Mitenko
Journal:  Clin Pharmacol Ther       Date:  1983-09       Impact factor: 6.875

8.  Contribution of lungs to total body clearance: linear and nonlinear effects.

Authors:  J M Collins; R L Dedrick
Journal:  J Pharm Sci       Date:  1982-01       Impact factor: 3.534

9.  Determination of opiates in biological samples by glass capillary gas chromatography with electron-capture detection.

Authors:  P O Edlund
Journal:  J Chromatogr       Date:  1981-02-06

10.  Kinetics of high-dose intravenous morphine in cardiac surgery patients.

Authors:  D R Stanski; D J Greenblatt; D G Lappas; J Koch-Weser; E Lowenstein
Journal:  Clin Pharmacol Ther       Date:  1976-06       Impact factor: 6.875

View more
  5 in total

1.  The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteers.

Authors:  P J Hoskin; G W Hanks; G W Aherne; D Chapman; P Littleton; J Filshie
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

2.  Pulmonary disposition of pethidine in postoperative patients.

Authors:  M P Persson; P Hartvig; L Wiklund; L Paalzow
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

3.  The influence of renal function on the renal clearance of morphine and its glucuronide metabolites in intensive-care patients.

Authors:  R W Milne; R L Nation; A A Somogyi; F Bochner; W M Griggs
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

Review 4.  The effect of respiratory disorders on clinical pharmacokinetic variables.

Authors:  A M Taburet; C Tollier; C Richard
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

Review 5.  The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients.

Authors:  A Bodenham; M P Shelly; G R Park
Journal:  Clin Pharmacokinet       Date:  1988-06       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.